[Federal Register Volume 66, Number 78 (Monday, April 23, 2001)]
[Rules and Regulations]
[Page 20401]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-9950]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 14

[Docket No. 00N-1634]


Public Hearing Before a Public Advisory Committee; Examination of 
Administrative Record and Other Advisory Committee Records; Withdrawal

AGENCY: Food and Drug Administration, HHS.

ACTION: Direct final rule; withdrawal.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) published in the 
Federal Register of January 8, 2001, a proposed rule (66 FR 1276) and a 
direct final rule (66 FR 1257) to amend FDA regulations governing the 
public disclosure of written information for consideration by an 
advisory committee at an advisory committee meeting. The comment period 
closed March 26, 2001. FDA is withdrawing the direct final rule because 
the agency received significant adverse comment.

DATES: The direct final rule published in the Federal Register of 
January 8, 2001 (66 FR 1257), is withdrawn as of April 23, 2001.

FOR FURTHER INFORMATION CONTACT: Andrea C. Masciale, Center for Drug 
Evaluation and Research (HFD-7), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-594-2041.
    Therefore, under the Federal Food, Drug, and Cosmetic Act, and 
under the authority delegated to the Commissioner of Food and Drugs, 
the direct final rule published in the Federal Register of January 8, 
2001 (66 FR 1257), is withdrawn.

    Dated: April 17, 2001.
Ann M. Witt,
Acting Associate Commissioner for Policy.
[FR Doc. 01-9950 Filed 4-20-01; 8:45 am]
BILLING CODE 4160-01-S